(Q34446019)

2 August 2017

1 reference

title

Neuroprotective peptide drug delivery and development: potential new therapeutics (English)

1 reference

2 August 2017

1 reference

Gozes I

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

2 August 2017

published in

Trends in Neurosciences

1 reference

2 August 2017

volume

24

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

700-705

1 reference

Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: review and current status

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

The parkinsonian models: invertebrates to mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Optimal pregnancy outcome in a minimal-stimulation in vitro fertilization program.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Leuprolide acetate (30-mg depot every four months) in the treatment of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A peptide as a possible transmitter in sympathetic ganglia of the frog

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Intranasal gonadotropin-releasing hormone (GnRH) therapy for men with idiopathic infertility: GnRH stimulation test may predict response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Aqueous vasopressin infusion during chemotherapy in patients with diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Memory deficit in rats with hereditary diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Neuromodulation of memory in the hippocampus by vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

History and use of oxytocics

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Social amnesia in mice lacking the oxytocin gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

The neurobiology of attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Backbone cyclic peptide antagonists, derived from the insect pheromone biosynthesis activating neuropeptide, inhibit sex pheromone biosynthesis in moths

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Recent developments in computational proteomics.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Target-oriented and diversity-oriented organic synthesis in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Differential transport of rat and human interleukin-1alpha across the blood-brain barrier and blood-testis barrier in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport (RMP-7).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Delivery of peptides and proteins through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Acute application of NGF increases the firing rate of aged rat basal forebrain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A non-invasive transport system for GDNF across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

TAT-mediated protein transduction into mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Improvements in the selective perception and training of rats using an original analog of the C-terminal fragment of vasopressin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Quantitative analysis of the olfactory pathway for drug delivery to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Preparation of desmopressin-containing liposomes for intranasal delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Pronounced effect of caprylocaproyl macrogolglycerides on nasal absorption of IS-159, a peptide serotonin 1B/1D-receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A femtomolar-acting neuroprotective peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Cloning and characterization of the human activity-dependent neuroprotective protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A new concept in the pharmacology of neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A novel peptide prevents death in enriched neuronal cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Nuclear factor-kappaB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

A glia-derived signal regulating neuronal differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

Nerve growth factor (NGF) loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2901931-7

7 January 2021

10.1016/S0166-2236(00)01931-7

Identifiers

DOI

1 reference

2 August 2017

1 reference